Bio-Medical Applictions Of Tennessee Inc in Memphis, Tennessee - Dialysis Center

Bio-Medical Applictions Of Tennessee Inc is a medicare approved dialysis facility center in Memphis, Tennessee and it has 19 dialysis stations. It is located in Shelby county at 4601 Quince Road, Memphis, TN, 38117. You can reach out to the office of Bio-Medical Applictions Of Tennessee Inc at (901) 767-0223. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Bio-Medical Applictions Of Tennessee Inc has the following ownership type - Profit. It was first certified by medicare in January, 2016. The medicare id for this facility is 442731 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameBio-Medical Applictions Of Tennessee Inc
Location4601 Quince Road, Memphis, Tennessee
No. of Dialysis Stations 19
Medicare ID442731
Managed ByFresenius Medical Care
Ownership TypeProfit
Late Shifts No

Contact Information


4601 Quince Road, Memphis, Tennessee, 38117
(901) 767-0223

Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Bio-Medical Applictions Of Tennessee Inc from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1639591951
Organization NameFresenius Medical Care Central Memphis
Doing Business AsBio-medical Applications Of Tennessee, Inc.
Address4601 Quince Rd Memphis, Tennessee, 38117
Phone Number(901) 767-0223

Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data20
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL25

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center33
    Adult patient months included in Kt/V greater than or equal to 1.2222
    Percentage of adult patients getting regular hemodialysis at the center99
    Percentage of pediatric patients getting regular hemodialysis at the center

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Bio-Medical Applictions Of Tennessee Inc with elevated calcium levels.

Patients with hypercalcemia38
Hypercalcemia patient months243
Hypercalcemia patients with serumcalcium greater than 10.2 mg2
Patients with Serumphosphor40
Patients with Serumphosphor less than 3.5 mg/dL6
Patients with Serumphosphor from 3.5 to 4.5 mg/dL26
Patients with Serumphosphor from 4.6 to 5.5 mg/dL35
Patients with Serumphosphor from 5.6 to 7 mg/dL20
Patients with Serumphosphor greater than 7 mg/dL12

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 39
Patient months included in arterial venous fistula and catheter summaries 235
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment78
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer12

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary20
Hospitalization Rate in facility71.2 (As Expected)
Hospitalization Rate: Upper Confidence Limit356.6
Hospitalization Rate: Lower Confidence Limit16.1

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Bio-Medical Applictions Of Tennessee Inc were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility8.8 (As Expected)
Readmission Rate: Upper Confidence Limit39.3
Readmission Rate: Lower Confidence Limit.3